Specialties
Cardiology
Chronic Disease
Dermatology
Emergency
Endocrinology
Gastroenterology
Imaging and Intervention
Infectious Disease
Nephrology
Neurology
Obstetrics
Oncology
Ophthalmology
Pediatrics
Preclinical
Psychiatry
Public Health
Pulmonology
Surgery
Urology
Classics™
Rewinds
Click for the Rewinds Archive
Power Rankings™
Patients
Subscribe
Write for Us
Writer Application
Submit an Opinion
For Partners
License Content
Submit Press Release
Advertise with Us
Search
Friday, November 15, 2019
About
Masthead
License Content
Advertise
Submit Press Release
RSS/Email List
Write for us
Contact us
2 Minute Medicine
Specialties
All
Cardiology
Chronic Disease
Dermatology
Emergency
Endocrinology
Gastroenterology
Imaging and Intervention
Infectious Disease
Nephrology
Neurology
Obstetrics
Oncology
Ophthalmology
Pediatrics
Preclinical
Psychiatry
Public Health
Pulmonology
Surgery
Urology
Odanacatib for the treatment of postmenopausal osteoporosis
Association of Widespread Adoption of the 39-Week Rule With Overall Mortality…
The 3 Wishes Project: a valuable program to improve end-of-life care
Selective Vulnerability of the Nucleus Basalis of Meynert Among Neuropathologic Subtypes…
Classics™
Rewinds
2 Minute Medicine Rewind November 4, 2019
2 Minute Medicine Rewind October 28, 2019
2 Minute Medicine Rewind October 21, 2019
2 Minute Medicine Rewind October 14, 2019
2 Minute Medicine Rewind October 7, 2019
Click for the Rewinds Archive
Power Rankings™
Patients
Subscribe
Write for Us
Writer Application
Submit an Opinion
For Partners
License Content
Submit Press Release
Advertise with Us
Tag: bevacizumab
#VisualAbstract: Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer
Constance Wu
-
November 5, 2019
0
Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer: A...
Donna Leet
-
October 20, 2019
0
2 Minute Medicine Rewind October 14, 2019
Donna Leet
-
October 14, 2019
0
2 Minute Medicine Rewind April 22, 2019
Aliya Ramjaun
-
April 22, 2019
0
Adding bevacizumab may not improve breast cancer survival
Monica Parks
-
March 12, 2015
0
Bevacizumab may aid tuberculosis therapy [PreClinical]
Jessica Lau
-
January 31, 2015
0
No increased overall risk of systemic events with use of anti-VEGF...
Swarup Swaminathan, MD
-
July 26, 2014
0
Becavizumab may improve progression free survival in platinum-resistant ovarian cancer
Monica Parks
-
March 21, 2014
0
2 Minute Medicine Rewind February 17 – February 23, 2014
David Ouyang, MD
-
February 24, 2014
0
First line bevacizumab fails to improve survival newly diagnosed glioblastoma patients...
Tomi Jun, MD
-
February 23, 2014
0
1
2
Page 1 of 2
All-time hits
The Child-Pugh score: Prognosis in chronic liver disease and cirrhosis [Classics...
July 16, 2013
The CLOT trial: Dalteparin versus warfarin [Classics Series]
December 7, 2014
Updated JNC 8 guidelines for antihypertensive drugs released
December 19, 2013
